Indeed, during the first wave, the frequency of GZMB, CD107a, CD39, and PD-1-expressing Tconv cells was significantly higher in MD and SD patients, but CD4+ Tconv cells showed no impairment in cytokine production. This evidence concerns the gene CD4 and Salla disease.